庆大霉素类组分的化学研究 V. 庆大霉素M的结构的鉴定

庆大霉素M(4)系首次从小单孢属菌F51-37变异菌株27^#的发酵液中, 分得的一种碱性氨基糖苷类抗生素, m.p.120-126C, C21H11N6O4.m/Z:491(M^+), 在酸性甲醇溶液中水解降解后, 分得2-脱氧链霉胺(5), 加拉霉胺(7), 庆大霉胺(8)和甲基-β-加拉糖胺; 结合核磁共振及质谱分析, 确定了它的结构为6'-N-乙醛基庆大霉素。     

庆大霉素类组分的化学研究 Ⅴ.庆大霉素M的结构鉴定

庆大霉素M(4)系首次从小单孢属菌F_(54-37)变异菌株27~#的发酵液中,分得的一种碱性氨基糖苷类抗生素.m.p.120—126℃.C_(21)H_(41)N_4O_8.m/s:491(M~+)。在酸性甲醇溶液中水解降解后,分得2-脱氧链霉胺(5)、加拉霉胺(7)、庆大霉胺(8)和甲基-β-加拉糖胺;结合核磁共振及质谱分析,确定了它的结构为6′-N-乙酰基庆大霉素。     

水母雪莲化学成分的研究（Ⅱ）

前文已报道从水母雪莲(Saussurea Medusa Maxim)中分得4种黄酮甙,本文报道另外6种化合物的分离和鉴定。 1 化合物Ⅰ—Ⅳ物化性质及分离鉴定 1.1 化合物Ⅰ 黄色结晶,m.p.:249～251℃,水解所得甙元鉴定为木樨草素,纸层析检出鼠李糖和葡萄糖。MS(FAB):m/z 595(M~++1),287(M~++H-葡萄糖基-鼠李糖)。化合物I与木樨草素的~(13)C NMR比较,C_6、C_8、C_(10)分别向低场位移1.1、1.0、1.8 ppm,而C,向高场移动     

聚茜素红薄膜修饰电极对硫酸庆大霉素的电催化作用

利用聚茜素红薄膜修饰电极的电催化作用,建立了对硫酸庆大霉素含量进行定量分析的一种电分析方法.在0.02 mol/L PBS(pH=6.86)+0.2 mol/L KNO3+5.0×10-4 mol/L ARS的聚合体系中,利用循环伏安法(CV)电聚合制备聚茜素红薄膜修饰电极(PARSE).PARSE对硫酸庆大霉素具有良好的电催化作用,在0.10 mol/L HCl溶液中,硫酸庆大霉素的浓度在0.4~4.0 mg/mL范围内与峰电流呈良好的线性关系,线性回归方程和线性相关系数分别为:ip(μA) = 0.0395C(mg/mL) + 2.1499,γ= 0.9984,检出限可达0.04 mg/mL.利用该法对硫酸庆大霉素针剂进行定量分析,得到满意结果.10次样品分析结果的相对标准偏差小于4%,完全满足微量分析的要求.     

2-甲氧亚胺基-2-(多取代苯基)乙酸甲酯类化合物合成及杀菌活性

以取代甲苯为原料,与草酰氯单甲酯反应生成傅克酰基化产物2-羰基-2-(邻甲基苯基)乙酸甲酯(A),A与甲氧基胺盐酸盐反应得到(Z/E)-2-(甲氧亚胺基)-2-(邻甲基苯基)乙酸甲酯(B),B与溴单质反应得到中间体(Z/E)-2-(2-溴甲基)苯基-2-甲氧亚胺基乙酸甲酯(C).E-2-甲氧亚胺基-(2-溴甲基苯基)乙酸甲酯(E)用硝酸硝化得到中间体E-2-甲氧亚胺基-(2-溴甲基-5-硝基苯基)乙酸甲酯(F).中间体C和F与芳香酮肟经过缩合反应生成甲氧亚胺基-(4或5-取代基-2-(1-(3或4-取代苯基)-E-亚乙基胺氧甲基)苯基)乙酸甲酯化合物(D,E和G),H可以从G1还原得到.所得新化合物均通过1H NMR,13C NMR,19F NMR,IR和HRMS等确证.用生长速率法测试了目标化合物对黄瓜灰霉、番茄早疫、小麦赤霉、辣椒疫霉、油菜菌核和水稻纹枯等6种真菌的离体抑菌活性.结果表明,部分目标化合物比肟菌酯有更高的杀菌活性.     

高效液相色谱法测定庆大霉素C组分的不同检测方式测定结果的比较

各国药典中关于庆大霉素C组分的测定方法均为高效液相色谱法,但检测方式及分离效果不同。为此采用直观推导式演进特征投影法(HELP),对高效液相色谱-二极管阵列检测采集的庆大霉素C组分色谱数据进行解析,分辨出各物质的色谱曲线,在扣除了未分离的杂质峰对庆大霉素C1组分的干扰后,对柱前邻苯二醛衍生化-二极管阵列检测法及目前中国药典 2005 版收载的高效液相色谱-蒸发光散射检测方法测定庆大霉素C组分的准确性进行了比较,并运用柱切换技术,证明二者测定结果的一致性。     

4-偕胺肟双吡啶季铵碘盐的合成

双吡啶醛肟季铵盐类对某些有机磷酸酯类中毒具有明显的对抗作用,因此合成了一类4-偕胺肟双吡啶季铵碘盐化合物(1a～1n),以期找出更有效的抗毒剂. CONR_2取代在3位:NR_2=NH_2(a),N(CH_3)_2(b),N(C_2H_5)2(c),NHC_3H_(7-n)(d),NHC_3H_(7-i)(e),NHC_4H_9n(f),NHC_4H_(9-i)(g), CONR_2取代在4位:NR_2=NH_2(1),NHC_3H_(7-n)(m),这类新化合物的合成是以4-吡啶甲酸(2)制得4-氰基吡啶(3),再与盐酸羟胺作用制得4-吡啶偕胺肟(4),然后与α,α’-二氯甲醚作用制得N-氯甲氧甲基-4-吡啶偕胺肟氯盐(简称单氯盐,5),最后与相应的N-取代吡啶甲酰胺(6)作用而得.     

Synthesis, Characterization and Crystal Structure of （＋）-N-[（3S）-3-（4- fluoroph enyl）heptan oyl] bornan e-10,2-s ultam

The chiral molecule (+)-N-[(3S)-3-(4-fluorophenyl)heptanoyl]bornane-10,2-sultam (C23H32FNO3S, Mr = 421.56), a fluorine-containing derivative of camphorsultam, was conveniently obtained and crystallized in the orthorhombic space group P212121 with a = 7.9044(11), b = 11.6680(16), c = 24.899(3) , V = 2296.4(5) 3, Z = 4, Dc = 1.219 Mg/m3, λ = 0.71073 , μ(MoKα) = 0.172 mm-1 and F(000) = 904. X-ray diffraction analysis reveals that the six-membered ring of sultam shows a boat conformation (Fig. 1). The planes constructed by ((C6), (C7), (C8), (C9)) and ((C4), (C5), (C6), (C9)) form a dihedral angle of 70.3(3)°. The plane of (C1)-(C2)-(C3) forms dihedral angles to the aforementioned planes of 85.9(4) and 89.5(4)°, respectively. The molecules are linked via C-H···O/F interactions.     

冬凌草的化学成分研究

采用硅胶柱层析方法从冬凌草的全草乙醇提取物中分离了7个化合物,通过理化性质和波谱分析方法分别鉴定为豆甾醇(Ⅰ),β-谷甾醇(Ⅱ),冬凌草乙素(Ⅲ),lasiodon in(Ⅳ),冬凌草甲素(Ⅴ),5,3,′4′-三羟基-6,7-二甲氧基黄酮(Ⅵ)和胡麻素(Ⅶ).化合物Ⅰ为首次从该属植物中分得,化合物Ⅵ为首次从该植物中分得.     

贡甲根中生物碱的化学研究

从芸香科植物贡甲(Acronychia oligophylebia Merr.)的根中分得了九个生物碱1～9和β-谷甾醇(10),其中吴茱萸春(1)、香草木宁(3)、原茵芋碱(4)、茵芋碱(5)和斑点弗林定(6)是已知生物碱,1,4,6三个生物碱是第一次从山油柑属植物中分得.贡甲定碱(2)和贡甲辛定碱(9)是两个新化合物.贡甲辛碱(7)和贡甲碱(8)是首次从植物中分得.用光谱方法推断了2,7,8,9的结构,由合成证明7,9的结构. 7和8具广谱抗真菌作用,但作用较弱.     

Preparative purification of gentamicin components using high-speed counter-current chromatography coupled with electrospray mass spectrometry

We developed a useful and preparative method based on high-speed counter-current chromatography with mass spectrometry (HSCCC/MS) to purify gentamicin C1a, C2/2a and C1 from standard powder. The analytes were purified on the HSCCC model CCC-1000 (multi-layer coil planet centrifuge) with a volatile two-phase solvent system composed of n-butanol/10% aqueous ammonia solution (50:50, v/v) and detected on an LCMS-2020EV quadrupole mass spectrometer fitted with an electrospray ionization (ESI) source system in positive ionization following scan mode (m/z 100-500). The HSCCC/ESI-MS peaks indicated that gentamicin C1a (m/z 450: [M+H](+)), C2/2a (m/z 464: [M+H](+)) and C1 (m/z 478: [M+H](+)) have the peak resolution values of 1.3 and 1.7 from 30 mg of loaded gentamicin powder. The HSCCC yielded 3.9 mg of gentamicin C1a, 12.6 mg of gentamicin C2/2a and 12.0 mg of gentamicin C1. These purified substances were analyzed by LC/MS with scan positive-mode. Based on the LC/MS chromatograms and spectra of the fractions, analytes were estimated to be over 95% pure. These gentamicin isomers of C1a, C2/2a and C1 were evaluated for their antibacterial activities. The overall results indicate that this approach of HSCCC/MS is a powerful technique for the purification of gentamicin components.     

Development of an enzyme-linked immunosorbent assay for gentamicin in human blood serum

An enzyme-linked immunosorbent assay (ELISA) for the quantitative detection of gentamicin in human blood serum was developed. Peculiarities of the adsorption on the microtitre plate surface of the gentamicin-protein conjugate were investigated. Different conditions of the competition stage of the analysis were studied and conditions for gentamicin monitoring in human blood serum in the clinical range were optimized. The matrix effect on the assay results, the specificity of the analytical system and the stability of the reagents were examined. The method permits gentamicin concentrations to be determined in human blood serum, diluted 1/1000, in the linear range from 1 to 30 ng/mL. The assay is characterized by high sensitivity (0.5 ng/mL), good reproducibility (CV < 12%) and good correlation with PFIA (r = 0.943). Received: 17 June 1997 / Revised: 30 September 1997 / Accepted: 2 October 1997     

Development of an enzyme-linked immunosorbent assay for gentamicin in human blood serum

An enzyme-linked immunosorbent assay (ELISA) for the quantitative detection of gentamicin in human blood serum was developed. Peculiarities of the adsorption on the microtitre plate surface of the gentamicin-protein conjugate were investigated. Different conditions of the competition stage of the analysis were studied and conditions for gentamicin monitoring in human blood serum in the clinical range were optimized. The matrix effect on the assay results, the specificity of the analytical system and the stability of the reagents were examined. The method permits gentamicin concentrations to be determined in human blood serum, diluted 1/1000, in the linear range from 1 to 30 ng/mL. The assay is characterized by high sensitivity (0.5 ng/mL), good reproducibility (CV < 12%) and good correlation with PFIA (r = 0.943). Received: 17 June 1997 / Revised: 30 September 1997 / Accepted: 2 October 1997     

Determination of gentamicin in pharmaceutical formulations using peroxyoxalate chemiluminescent detection in flow-injection analysis

A simple and sensitive procedure for the determination of gentamicin is presented, based on the use of the peroxyoxalate chemiluminescent (PO-CL) system in presence of imidazole as a catalyst. The gentamicin has to be previously derivatized with o-phthaladehyde (OPA) in order to obtain a fluorophore, which participates in the PO reaction, producing a CL emission proportional to the gentamicin concentration. The method is developed by using a particular flow-injection analysis (FIA) manifold, employing sodium dodecyl sulfate (SDS) micellar medium as a carrier in order to avoid the degradation of PO in water. The optimization of the instrumental and chemical variables affecting the CL reaction was rigorously carried out by using experimental design methodology. The method has been successfully applied to pharmaceutical formulations.     

Impurity analysis of gentamicin bulk samples by improved liquid chromatography-ion trap mass spectrometry

Several gentamicin bulk samples from different origins were investigated using an LC/MS method.LC equipped with ion trap MS with positive ionization was performed on a Capcell Pak C18(AQ) column with the mobile phase containing 50 mM trifluoroacetic(TFA) and methanol.Impurities present in batches of gentamicin bulk samples were elucidated and compared according to their fragmentation behavior.In total seventeen impurities present in samples,five impurities were not elucidated and two compounds were identifi...     

Sample preparation for residue determination of gentamicin and neomycin by liquid chromatography

The effect of sample preparation on the determination of gentamicin and neomycin residues in animal tissues was investigated. The extract was mixed with an ion-pair reagent and applied to an octadecyl cartridge. The cartridges were washed with buffer followed by water, and analytes were eluted with ion-pair buffer-acetonitrile mixture. The aminoglycosides were derivatized with 9-fluorenylmethyl chloroformate prior to liquid chromatography using a reversed-phase column and fluorescence detection. Under the conditions applied neomycin was fully separated from all the gentamicin compounds. The highest recoveries of gentamicin and neomycin from spiked tissues were obtained using trichloroacetic acid after initial extraction with phosphate-buffered saline. No interfering peaks from endogenous compounds of matrix were noted at the elution position of the analytes. An intra-laboratory validation of the whole procedure was performed. The calibration graphs were linear from 0.1 to 1.0 mg/kg for gentamicin, and from 0.2 to 1.0 mg/kg for neomycin. Limits of detection were 0.05 mg/kg and 0.10 mg/kg for gentamicin and neomycin, respectively. Limits of quantitation for gentamicin and neomycin were 0.1 and 0.20 mg/kg muscle, liver or kidney tissue, respectively. Recoveries of gentamicin spiked at levels of 0.1 mg/kg porcine tissues ranged from 76 to 86%. Recoveries of neomycin spiked at levels of 0.2 mg/kg porcine tissues ranged from 77 to 83%. The validated procedure was used to determine gentamicin concentrations in porcine tissue after dosing with gentamicin at a level of 5 mg/kg body mass.     

Improved liquid chromatographic method with pulsed electrochemical detection for the analysis of gentamicin

The official method for the determination of the composition and related substances of gentamicin prescribed by the European Pharmacopoeia (Ph. Eur.) is liquid chromatography combined with pulsed electrochemical detection (LC-PED). However, this method utilizes a polymer stationary phase which shows rather low efficiency towards the separation of the main gentamicin components. Moreover, the mobile phase contains a lot of non volatile salts: sodium sulphate and sodium octanesulphonate. Following a comparative study, the most performant LC-PED method has been evaluated and validated using a reversed phase C18 column (C18, 250 x 4.6mm ID, 110 A, 5 microm) kept at 35 degrees C with a mobile phase containing volatile ion pairing agents: trifluoroacetic acetic acid (TFA) and pentafluoropropionic acid (PFPA). In addition to the selectivity of the main gentamicin components and its related substances, the method is repeatable, linear and proves to be robust. It is also applicable to a wider number of C18 columns.     

Determination of gentamicin in swine and calf tissues by high-performance liquid chromatography combined with electrospray ionization mass spectrometry

Gentamicin is a broad-spectrum aminoglycoside antibiotic widely used in veterinary medicine for the treatment of serious infections. The purpose of this study was to develop and validate a method to determine gentamicin residues in edible tissues of swine and calf. Extraction of gentamicin was performed using a liquid extraction with phosphate buffer containing trichloroacetic acid, followed by a solid-phase clean-up procedure on a CBA weak cation-exchange column. Tobramycin was used as the internal standard. After drying of the eluate, the residue was redissolved and further analyzed by reversed-phase liquid chromatography/electrospray ionization tandem mass spectrometry (MS/MS). Chromatographic separation of the internal standard tobramycin and the gentamicin components was achieved on a Nucleosil (5 microm) column using a mixture of 10 mM pentafluoropropionic acid in water and acetonitrile as the mobile phase. The gentamicin components C1a, C2 + C2a and C1 could be identified with the MS/MS detection, and subsequently quantified. The method was validated according to the requirements of the EC at the maximum residue limit (MRL) (100 ng g(-1) for muscle and fat, 200 ng g(-1) for liver and 1000 ng g(-1) for kidney), half the MRL and double the MRL levels. Calibration graphs were prepared for all tissues and good linearity was achieved over the concentration ranges tested (r > 0.99 and goodness of fit <10%). Limits of quantification of 25.0 ng g(-1) were obtained for the determination of gentamicin in muscle, fat, liver and kidney tissues of swine and calf, which correspond in all cases to at least half the MRLs. Limits of detection ranged between 0.5 and 2.5 ng g(-1) for the tissues. The within-day and between-day precisions (RSD) and the results for accuracy fell within the ranges specified. The method was successfully used for the determination of gentamicin in tissue samples of swines and calves medicated with gentamicin by intramuscular injection.     

Complexation of aminoglycoside antibiotics with metal cations as a derivatization reaction: Determination of gentamicin by equilibrium electrochemical and spectrophotometric methods

The complexation of aminoglycoside antibiotics with metal cations was proposed as a derivatization method for the further determination of the complex obtained by potentiometry with ion-selective electrodes (ISE), voltammetry at the interface between two immiscible electrolyte solutions (ITIES), and spectrophotometry. It was shown by the spectrophotometric method that gentamicin formed a 1: 1 complex with copper(II). For the potentiometric determination of gentamicin, we obtained ionophores that were ion associates formed by the gentamicin complex of copper(II) and tetraphenylborate derivatives as counterions. The transfer of the gentamicin complex of copper(II) was studied voltammetrically at the ITIES. The results obtained indicate that l antibiotic gentamicin can be directly determined as a complex with copper(II) by potentiometric, voltammetric, and spectrophotometric methods.